ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2026
Construct length rather than interbody spacer material is associated with reoperation after anterior cervical discectomy and fusion.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWe compared reoperation after primary anterior cervical discectomy and fusion (ACDF) performed with structural allograft versus synthetic interbody cage, and we characterized the indications for revision in each group. Comparative data on interbody spacer selection derive largely from series with approximately one year of observation in which radiographic nonunion, rather than reoperation, is the endpoint. Whether spacer material alters the need for revision over a longer horizon remains unresolved.
methodsWe identified all consecutive patients undergoing primary ACDF for degenerative disease at a single academic center between January 2016 and July 2021, requiring a minimum of 24 months of follow-up. Pseudarthrosis and adjacent segment disease were defined as symptomatic failure requiring reoperation and were abstracted from operative reports by two independent reviewers. The primary analysis was a multivariable Cox proportional hazards model adjusting for age, Charlson Comorbidity Index (CCI), and number of fused levels. Propensity score matching was retained as a sensitivity analysis.
resultsOf 588 procedures screened, 248 patients met criteria (211 allograft, 37 cage). Mean age was 55.1 ± 10.2 years and 39.9% were male, with a median follow-up of 44.5 months (IQR 33.3-55.9). Revision was performed in 32 of 211 allograft patients (15.2%) and 4 of 37 cage patients (10.8%, P = 0.618). Estimated freedom from revision at two years was 90.9% and 91.9% (log-rank P = 0.619). Cage was not associated with revision after adjustment (hazard ratio 0.90, 95% CI 0.30-2.65). Three-level fusion was associated with revision relative to single-level fusion (hazard ratio 2.96, 95% CI 1.13-7.76, P = 0.028). Adjacent segment disease was the leading indication in both groups. Anterior plate fixation was used in 99.5% of allograft constructs but in only 33.3% of cage constructs with documented plate status.
conclusionsInterbody spacer material was not associated with reoperation in this cohort, whereas construct length was. With 36 events and a confidence interval extending to a 2.2-fold higher hazard, these data represent a null result under limited power rather than evidence of equivalence. Construct length warrants explicit discussion during preoperative counseling. Spacer material and construct configuration travelled together in this cohort, which has implications for how the existing comparative literature should be read.
Indexed as
Identifiers
42565850What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.